Frantz Foissac

1.6k total citations
71 papers, 1.0k citations indexed

About

Frantz Foissac is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, Frantz Foissac has authored 71 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Pediatrics, Perinatology and Child Health and 12 papers in Virology. Recurrent topics in Frantz Foissac's work include HIV/AIDS drug development and treatment (22 papers), Pharmacological Effects and Toxicity Studies (14 papers) and HIV Research and Treatment (12 papers). Frantz Foissac is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), Pharmacological Effects and Toxicity Studies (14 papers) and HIV Research and Treatment (12 papers). Frantz Foissac collaborates with scholars based in France, United States and Netherlands. Frantz Foissac's co-authors include Jean‐Marc Tréluyer, Naïm Bouazza, Saı̈k Urien, Déborah Hirt, Sihem Benaboud, Elodie Valade, Gabrielle Lui, Maïlys De Sousa Mendes, Hélène Chappuy and Stéphane Blanche and has published in prestigious journals such as JAMA, Annals of Surgery and Radiology.

In The Last Decade

Frantz Foissac

63 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frantz Foissac France	18	294	249	221	157	118	71	1.0k
Naïm Bouazza France	23	354 1.2×	340 1.4×	269 1.2×	207 1.3×	115 1.0×	94	1.6k
Arnaud D. Kazé United States	21	237 0.8×	97 0.4×	152 0.7×	274 1.7×	66 0.6×	62	1.6k
Jérôme Dimet France	16	153 0.5×	105 0.4×	117 0.5×	92 0.6×	134 1.1×	47	1.0k
Tom Blydt‐Hansen Canada	27	123 0.4×	388 1.6×	566 2.6×	471 3.0×	43 0.4×	116	3.6k
Juan P. Bosch United States	15	101 0.3×	150 0.6×	151 0.7×	190 1.2×	37 0.3×	26	2.1k
Stefan Herget‐Rosenthal Germany	28	68 0.2×	156 0.6×	95 0.4×	386 2.5×	19 0.2×	74	2.8k
José António Lopes Portugal	25	167 0.6×	78 0.3×	130 0.6×	423 2.7×	32 0.3×	95	2.0k
Johannes P. van Hooff Netherlands	37	133 0.5×	492 2.0×	415 1.9×	287 1.8×	21 0.2×	60	2.9k
Kenan Keven Türkiye	24	150 0.5×	119 0.5×	118 0.5×	312 2.0×	38 0.3×	113	1.9k
Reginald Gohh United States	25	177 0.6×	250 1.0×	266 1.2×	179 1.1×	86 0.7×	102	1.6k

Countries citing papers authored by Frantz Foissac

Since Specialization

Citations

This map shows the geographic impact of Frantz Foissac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frantz Foissac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frantz Foissac more than expected).

Fields of papers citing papers by Frantz Foissac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frantz Foissac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frantz Foissac. The network helps show where Frantz Foissac may publish in the future.

Co-authorship network of co-authors of Frantz Foissac

This figure shows the co-authorship network connecting the top 25 collaborators of Frantz Foissac. A scholar is included among the top collaborators of Frantz Foissac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frantz Foissac. Frantz Foissac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foissac, Frantz, et al.. (2025). Unfractionated Heparin Dosing in Pediatric Venoarterial Extracorporeal Membrane Oxygenation: Single-Center Retrospective Study, 2015–2021. Pediatric Critical Care Medicine. 27(3). 244–252.

Benaboud, Sihem, Laurent Chouchana, Sophie Gautier, et al.. (2025). WS02.06Elexacaftor/tezacaftor/ivacaftor pharmacokinetics and occurrence of behavioural disorders in children aged 2 to 5 years old. Journal of Cystic Fibrosis. 24. S5–S5.

Bouazza, Naïm, Frantz Foissac, Saı̈k Urien, et al.. (2025). Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study. Placenta. 168. 150–158.

Foissac, Frantz, Naïm Bouazza, Inès Gana, et al.. (2024). Optimization of vigabatrin dosage in children with epileptic spasms: A population pharmacokinetic approach. British Journal of Clinical Pharmacology. 90(8). 1900–1910. 1 indexed citations

Thy, Michaël, Saı̈k Urien, Naïm Bouazza, et al.. (2024). Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an in vitro model. Expert Opinion on Drug Metabolism & Toxicology. 21(3). 325–333.

Gaujoux, Sébastien, Jean‐Marc Regimbeau, Guillaume Piessen, et al.. (2024). Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial. Annals of Surgery. 280(2). 179–187. 10 indexed citations

Daste, Camille, Frantz Foissac, Hendy Abdoul, et al.. (2023). Differences in Disability Perception in Systemic Sclerosis: A Mirror Survey of Patients and Health Care Providers. Journal of Clinical Medicine. 12(4). 1359–1359.

Bouazza, Naïm, Aristides Dokoumetzidis, Catherijne A. J. Knibbe, et al.. (2022). General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children. British Journal of Clinical Pharmacology. 88(12). 4985–4996. 2 indexed citations

Thy, Michaël, Saı̈k Urien, Frantz Foissac, et al.. (2022). Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy. Antimicrobial Agents and Chemotherapy. 66(12). e0113522–e0113522. 5 indexed citations

10.

Thy, Michaël, Saı̈k Urien, Naïm Bouazza, et al.. (2022). Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy. Clinical Pharmacokinetics. 61(11). 1609–1621. 6 indexed citations

11.

Grassin‐Delyle, Stanislas, Michaëla Semeraro, Elodie Lamy, et al.. (2022). Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers. British Journal of Anaesthesia. 128(3). 465–472. 43 indexed citations

12.

Zheng, Yi, Gabrielle Lui, Naïm Bouazza, et al.. (2021). Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 196. 113923–113923. 6 indexed citations

13.

Lesclous, Philippe, et al.. (2020). Alendronate or Zoledronic acid do not impair wound healing after tooth extraction in postmenopausal women with osteoporosis. Bone. 137. 115412–115412. 12 indexed citations

14.

Zheng, Yi, Gabrielle Lui, Déborah Hirt, et al.. (2020). HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 182. 113119–113119. 24 indexed citations

15.

Urien, Saı̈k, Frantz Foissac, Naïm Bouazza, et al.. (2019). Population pharmacokinetics of meropenem in critically ill children with different renal functions. European Journal of Clinical Pharmacology. 76(1). 61–71. 33 indexed citations

16.

Dres, Martin, Pierre Hausfater, Frantz Foissac, et al.. (2017). Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study. International Journal of COPD. Volume 12. 1047–1056. 11 indexed citations

17.

Bouazza, Naïm, Tim R. Cressey, Frantz Foissac, et al.. (2016). Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients. Journal of Antimicrobial Chemotherapy. 72(2). 490–495. 3 indexed citations

18.

Mendes, Maïlys De Sousa, Gabrielle Lui, Yi Zheng, et al.. (2016). A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways. Clinical Pharmacokinetics. 56(5). 537–550. 52 indexed citations

19.

Dangouloff‐Ros, Volodia, Christophe Deroulers, Frantz Foissac, et al.. (2016). Arterial Spin Labeling to Predict Brain Tumor Grading in Children: Correlations between Histopathologic Vascular Density and Perfusion MR Imaging. Radiology. 281(2). 553–566. 79 indexed citations

20.

Bouazza, Naïm, Saı̈k Urien, Stéphane Blanche, et al.. (2014). Concentration-response Model of Lopinavir/Ritonavir in HIV-1–infected Pediatric Patients. The Pediatric Infectious Disease Journal. 33(8). e213–e218. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact